51精品少妇人妻AV一区二区,欧美肥胖老妇做爰,我的少妇邻居全文免费,久久久久人妻一区精品色

您好!歡迎訪問上海根生生物科技有限公司網(wǎng)站!
全國(guó)服務(wù)咨詢熱線:

15216781845

當(dāng)前位置:首頁(yè) > 產(chǎn)品中心 > > 其它耗材與試劑 > ant-mpt進(jìn)口支原體清除劑*Invivogen Plasmocin™ treatmen

進(jìn)口支原體清除劑*Invivogen Plasmocin™ treatmen

簡(jiǎn)要描述:進(jìn)口支原體清除劑*Invivogen Plasmocin™ treatmen,Invivogen Plasmocin™ treatment支原體清除試劑規(guī)格50 mg (2 x 1 ml)現(xiàn)貨,詳細(xì)產(chǎn)品信息請(qǐng)

  • 產(chǎn)品型號(hào):ant-mpt
  • 廠商性質(zhì):代理商
  • 更新時(shí)間:2024-04-16
  • 訪  問  量:7623

詳細(xì)介紹

進(jìn)口支原體清除劑*Invivogen Plasmocin™ treatmen

 

Plasmocin™

Mycoplasma Removal Agent

Plasmocin™ is used to cure cell lines infected by mycoplasma and related cell wall-less bacteria. 
PlasmocinPlasmocin™ can also be used as a routine addition in liquid media to prevent mycoplasma and more generally bacterial contamination in small and large animal cell cultures.
More info on Mycoplasma eradication

Plasmocin™ is a well-established antimycoplasma reagent. It contains two bactericidal components strongly active against mycoplasmas that allow their elimination in only 2 weeks. 
The first component acts on the protein synthesis machinery while the second acts on the DNA replication. These two specific and separate targets are found only in mycoplasmas and many other bacteria and are compley absent in eukaryotic cells.

Warning: InvivoGen's anti-mycoplasma products are suitable for research purposes only, and not for human or animal care.

 

  • Specifications
  • Docs
  • Contents
  • Description
  • Details
  • Citations

- Active on both free mycoplasmas and intracellular forms
- No resistance in liquid cultures of mycoplasmas
- No apparent adverse effect on cellular metabolism
- Active at low concentrations on a broad range of Gram positive and negative bacteria
- Eliminates mycoplasma in as little as 2 weeks
- Treat up to 25 cell lines in T75

 

  • TDS Plasmocin™ prophylactic : 25 mg (10 x 1 ml) (ant-mpp)
  • TDS Plasmocin™ treatment : 50 mg (2 x 1 ml) (ant-mpt)
  • MSDS Plasmocin™ prophylactic : 25 mg (10 x 1 ml) (ant-mpp) , 50 mg (2 x 1 ml) (ant-mpt)

 

Plasmocin™ is provided as a yellow solution at different concentrations:

-  25 mg/ml (Plasmocin™Treatment)

-  2.5 mg/ml (Plasmocin™ Prophylactic)

In contrast to other anti-mycoplasma compounds, Plasmocin™ is active on both free mycoplasmas and intracellular forms. This advantage is conferred by one component of Plasmocin™ which is actively transported into mammalian cells. It ensures that following treatment with Plasmocin™ a cell culture is not reinfected by mycoplasmas released from intracellular compartments of infected cells.

In all animal cell lines tested to date, even at five times the working concentration, no apparent adverse effect on cellular metabolism is observed.

No resistance in liquid cultures of mycoplasmas has ever been identified in repeated experiments attempting to measure the mutation rate. Therefore, development of resistant mycoplasma strains is virtually eliminated.

Plasmocin™ is also active at low concentrations on a broad range of Gram positive and Gram negative bacteria that are otherwise resistant to the mixture of streptomycin and penicillin, and exhibits no toxicity in eukaryotic cells.

Many cell lines infected by mycoplasmas have been successfully treated with Plasmocin™, including embryonic stem cells, hybridomas and retrovirus packaging cells.

Comparison of the most common anti-mycoplasma agents [1-3]

ProductSupplierTreatmentEase of useEfficacyCytotoxicityResistance
BM-CyclinRoche3 weeks-+++++/-
CiprobayBayer12 to 20 days++++/-+
MRAICN1 to 2 weeks++++/-+
PlasmocinInvivoGen2 weeks+++++/--

Antibiotics commonly used in cell culture are inactive on mycoplasma (e.g. penicillins and streptomycin). Three classes of antibiotics have been shown to kill mycoplasma at relatively low concentrations: tetracyclines, macrolides and quinolones. Tetracyclines and macrolides block the protein synthesis by interfering with ribosome translation, while quinolones inhibit the replication of bacterial DNA.
Several antibiotics are commercially available for the removal of mycoplasma: BM-cyclin (Roche) contains a macrolide and a tetracycline, Ciprobay (Bayer, available only with a prescription) and MRA (ICN) are both quinolones. Plasmocin™ is the only antimycoplasma reagent that combines a macrolide and a quinolone. Unlike BM-Cyclin that requires the sequential and cyclic use of 2 antibiotics, Plasmocin™ is ready-to-use and can be added to the culture medium directly. Furthermore, the 2 antibiotics in Plasmocin™ act on separate targets blocking protein synthesis and DNA replication, whereas the 2 antibiotics in BM-Cyclin are both inhibitors of protein synthesis. Therefore, Plasmocin™ is more effective in removing mycoplasma and prevents the appearance of resistant strains. In contrast to other anti-mycoplasma compounds, Plasmocin™ is active on both free mycoplasma as well as intracellular forms. This advantage is conferred by one component of Plasmocin™ which is actively transported into mammalian cells. It ensures that following treatment with Plasmocin™ a cell culture is not reinfected by mycoplasma released from intracellular compartments of infected cells. To date, no consistent and permanent alterations that affect the eukaryotic cells during and after the treatment have been detected[1].

1. Uphoff CC, Drexler HG., 2005. Eradication of mycoplasma contaminations. Methods Mol Biol. 290:25-34.
2. Somasundaram C. et al., 1992. Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.In Vitro Cell Dev Biol. 28A(11-12):708-10
3. Drexler HG. et al., 1994. Treatment of mycoplasma contamination in a large panel of cell cultures. In vitro Cell Dev Biol Anim. 30A(5):344-7

 

Recent articles using Plasmocin™

 

 

  • 2012 - J Virol Methods., Epub ahead of print
    Mycoplasma removal: Simple curative methods for viral supernatants.
    Baronti C, Pastorino B, Charrel R, de Lamballerie X
  • 2011 - Mol Pharmacol., 80(6):1066-75
    Ca2+/calmodulin-dependent kinase (CaMK) signaling via CaMKI and AMP-activated protein kinase contributes to the regulation of WIPI-1 at the onset of autophagy.
    Pfisterer SG, Mauthe M, Codogno P, Proikas-Cezanne T
  • 2011 - J Immunol., 186(12):6822-6829
    Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80.
    Haile ST, Bosch JJ, Agu NI, Zeender AM, Somasundaram P, Srivastava MK, Britting S, Wolf JB, Ksander BR, Ostrand-Rosenberg S
  • 2012 - J. Biol. Chem., 287: 8082 - 8091
    Loss of lysosomal ion channel transient receptor potential channel mucolipin-1 (TRPML1) leads to cathepsin B-dependent apoptosis.
    Colletti GA, Miedel MT, Quinn J, Andharia N, Weisz OA, Kiselyov K
  • 2012 - Immunity, 36(3):464-476
    An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.
    Khare S, Dorfleutner A, Bryan NB, Yun C, Radian AD, de Almeida L, Rojanasakul Y, Stehlik C

 

 

ORDERING

Plasmocin™ prophylactic

DescriptionRemoval agent to prevent mycoplasma contamination
Cat. Codeant-mpp
Unit Size25 mg (10 x 1 ml)
PricePlease contact our distributor

 

  • TDS
  • MSDS

 

Plasmocin™ treatment

DescriptionRemoval agent to eliminate mycoplasmas
Cat. Codeant-mpt
Unit Size50 mg (2 x 1 ml)
PricePlease contact our distributor

 

  • TDS
  • MSDS

 

YOU MAY ALSO NEED

PlasmoTest™Detection of mycoplasma contamination in cell culture kit
Normocin™Antimicrobial agent for prevention against Mycoplasma, Bacteria and Fungi
Fungin™Antimicrobial agent for prevention and elimination of Fungi
G418Selection antibiotic for the neo gene
PuromycinSelection antibiotic for the pac gene

產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
上海根生生物科技有限公司
地址:上海市奉賢區(qū)南橋鎮(zhèn)南橋路377號(hào)1幢
郵箱:genshengtech@163.com
傳真:86-021-64190979
關(guān)注我們
歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
歡迎您關(guān)注我們的微信公眾號(hào)
了解更多信息
九月婷婷人人澡人人添人人爽| 免费毛片在线看不用播放器| 在线观看国产精品| 东北浪妇交换俱乐部| 五十路六十路老熟妇A片| 四虎永久在线精品无码| 欧美大屁股XXXX高跟欧美黑人| 国产美女极度色诱视频WWW| 国产av电影在线观看| 日韩吃奶摸下aa片免费观看| 女同互慰高潮呻吟免费播放| 久久久久亚洲av无码专区体验| 少妇搡BBBB搡BBB搡| 亚洲精品无码久久久久苍井空| 日本少妇高潮喷水XXXXXXX| 天堂中文在线资源库| 无码人妻丰满熟妇啪啪网站| 欧美日韩人妻精品一区二区三区| 被按摩的人妻中文字幕| 国产精品99久久久久久人四虎 | 日韩在线视频| 亚洲爆乳精品无码一区二区三区| 国产视频在线观看| 日本三级韩国三级韩级| 日本潮水RAPPER超多| 狠狠躁日日躁夜夜躁2022麻豆| 人人妻人人玩人人澡人人爽| A片扒开双腿进入做爽爽| А天堂中文在线官网在线| 亚洲欧洲精品a片久久99| 一本久道综合色婷婷五月| 免费观看全黄做爰的视频| AV人摸人人人澡人人超碰妓女| 国产精品理论片在线观看| 调教YIN荡女友系列合集| 玩弄丰满少妇高潮A片推油小说| 男男调教后菊撑开扩张A片| 亚洲人成色777777精品音频| CAOPORN成人免费公开| 短篇公交车高H肉辣全集目录| 国产精品久久久久精品三级|